115370 Results

People

  1. Ladanyi
    Ladanyi
  2. Motzer
    Motzer
  3. Reuter
    Reuter
  4. Scher
    Scher
  5. Brennan
    Brennan
  6. Giralt
    Giralt
  7. Gonen
    Gonen
  8. Perales
    Perales
  9. Hudis
    Hudis
  10. Jarnagin
    Jarnagin

Groups

  1. Department of Medicine (39033)
  2. GSK Faculty (22468)
  3. Solid Tumor Oncology Division (22056)
  4. Surgery (21247)
  5. Sloan Kettering Institute Faculty (16086)
  6. Survivorship Research (15762)
  7. Center for Hematologic Malignancies (13263)
  8. Hematologic Malignancies, Division of (13087)
  9. Sloan Kettering Institute Postdocs (12936)
  10. Department of Pathology and Laboratory Medicine (12615)
Formats
  1. Journal Article (66746)
  2. Meeting Abstract (33620)
  3. Book Section (5027)
  4. Review (3744)
  5. Editorial (2162)
  6. Conference Paper (1525)
  7. Correspondence (661)
  8. Guidelines (660)
  9. Research Letter (548)
  10. Miscellaneous (339)
  11. Book Whole (338)
Groups
  1. Department of Medicine (39033)
  2. GSK Faculty (22468)
  3. Solid Tumor Oncology Division (22056)
  4. Surgery (21247)
  5. Sloan Kettering Institute Faculty (16086)
  6. Survivorship Research (15762)

More Groups

People
  1. Marc Ladanyi (1327)
  2. Robert Motzer (1243)
  3. Victor Reuter (1228)
  4. Howard Scher (1130)
  5. Murray Brennan (1059)
  6. Sergio Giralt (1050)

More People

Years
  1. 2025 (1982)
  2. 2024 (5377)
  3. 2023 (5804)
  4. 2022 (6168)
  5. 2021 (5712)
  6. 2020 (5598)

More Years

Publications
  1. Journal of Clinical Oncology (8590)
  2. Blood (4950)
  3. Cancer Research (2701)
  4. International Journal of Radiation Oncology, Biology, Physics (2610)
  5. Laboratory Investigation (1879)
  6. Modern Pathology (1812)

More Publications

Publishers
  1. Elsevier Inc. (13855)
  2. American Society of Clinical Oncology (9157)
  3. Springer (7152)
  4. Nature Publishing Group (6367)
  5. American Association for Cancer Research (6002)
  6. Elsevier Science, Inc. (5503)

More Publishers

Results (115370)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A reproducible pipeline for analysis of multiplex imaging (MIBI) data with application to uncovering novel features of the tumorimmune microenvironment
    Meeting Abstract

    Maxey, J.; Thompson, M.; Campbell, K.; Kamphaus, B.; Bustami, Z.; Santulli-Marotto, S.; Wells, D.; Boffo, S.; Salvador, L.; Scumpia, P.; more...
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • LDH inhibition improves response to CTLA-4 blockade by enhancing effector T cell activity and impairing regulatory T cell suppression
    Meeting Abstract

    Verma, S.; Serganova, I.; Budhu, S.; Dong, L.; Mangarin, L.; Ko, M.; Blasberg, R.; Zappasodi, R.; Wolchok, J.; Merghoub, T.
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • Lag3 blockade in combination with GITR improves anti-tumor immune responses in a preclinical melanoma model
    Meeting Abstract

    Maniyar, R.; Zappasodi, R.; Elhanati, Y.; St Jean, S.; Carrasco, S.; Greenbaum, B.; Wolchok, J.; Merghoub, T.
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • Targeting LSD1 rescues MHC-I antigen presentation and overcomes resistance to PD-L1 blockade therapy in small cell lung cancer
    Meeting Abstract

    Nguyen, E.; Chow, A.; Rudin, C.; Sen, T.; Taniguchi, H.
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • Trial in progress: A phase 1/2 open-label study (IOV-GM1-201) of talen-mediated PD-1-inactivated autologous tumor-infiltrating lymphocytes (TIL; IOV-4001) in patients with advanced melanoma and NSCLC
    Meeting Abstract

    Betof, A.; Wise-Draper, T.; He, K.; Sarnaik, A.; Thompson, J.; Finckenstein, F.; Hari, P.; Jagasia, M.; Desai, A.; Suzuki, A.; more...
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • Immune checkpoint blockade enhances cyclophosphamide induced anti-tumor immunity in a preclinical melanoma model
    Meeting Abstract

    George, M.; Betof, A.; Merghoub, T.; Hamadene, L.; Hirschhorn, D.; Houghton, A.; Wolchok, J.
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • Apr-246 induces an increase in tumor immunogenicity in a p53 independent manner
    Meeting Abstract

    Venkatesh, D.; Michels, J.; Lu, C.; Budhu, S.; George, M.; Ouerfelli, O.; Abrahmsen, L.; Zappasodi, R.; Wolchok, J.; Merghoub, T.
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • Pharmacokinetic and pharmacodynamic data from a phase 1 study of CI-8993 anti-vista antibody in patients with advanced solid tumors
    Meeting Abstract

    Noelle, R.; Johnson, M.; Rodon, J.; Zauderer, M.; Lewis, L.; Severgnini, M.; Parker, J.; Lane, M.; von Roemeling, R.; Martin, A.; more...
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • ITIL-306-201: A multicenter, first-in-human phase 1a/1b study of ITIL-306, an engineered autologous tumor-infiltrating lymphocyte (TIL) cell therapy product, in adults with advanced solid tumor
    Meeting Abstract

    Ward, J.; Ghobadi, A.; Liao, J.; Schoenfeld, A.; Tykodi, S.; Jiang, Y.; Le Gall, J.; Alvarez-Rodriguez, R.; Sherman, M.; Singson, T.; more...
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • Botensilimab, a novel innate/adaptive immune activator, plus or minus balstilimab (anti-PD-1) in "cold" and I-O refractory metastatic solid tumors
    Meeting Abstract

    Wilky, B.; El-Khoueiry, A.; Bullock, A.; Tsimberidou, A.; Mahadevan, D.; Margolin, K.; Trent, J.; Bockorny, B.; Moser, J.; Hosein, P.; more...
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save